APC Anti-Human CD19 Antibody[CB19]

Introducing the APC Anti-Human CD19 Antibody [CB19], a highly efficient and reliable solution for immunophenotyping and flow cytometry applications. This product is designed to accurately detect and quantify CD19 expression in human samples, enabling researchers and clinicians to gain valuable insights into various diseases and therapeutic interventions.

With a generous size of 20 tests, this antibody offers ample opportunities for experimentation and analysis. Its advanced formulation ensures consistent and reproducible results, allowing for confident interpretation and comparison of data across multiple experiments.

The APC Anti-Human CD19 Antibody [CB19] is meticulously manufactured using cutting-edge technology and stringent quality control measures. This guarantees exceptional specificity and sensitivity, minimizing the risk of false positives or negatives. Its high affinity for CD19 epitopes ensures optimal binding, facilitating precise identification and enumeration of CD19-positive cells.

This antibody is compatible with a wide range of sample types, including peripheral blood, bone marrow, and lymphoid tissues. Its versatility allows for seamless integration into various research and clinical settings, empowering users to explore CD19 expression patterns in diverse physiological and pathological contexts.

Furthermore, the APC Anti-Human CD19 Antibody [CB19] exhibits excellent stability and long shelf life, ensuring consistent performance and cost-effectiveness. Its user-friendly format simplifies workflow, enabling efficient and streamlined experimentation.

In summary, the APC Anti-Human CD19 Antibody [CB19] is a superior choice for researchers and clinicians seeking a robust and dependable tool for CD19 immunophenotyping. Its exceptional performance, compatibility, and ease of use make it an invaluable asset in the pursuit of scientific and medical advancements.